Home Search
drug prices - search results
If you're not happy with the results, please do another search
Rx for Disaster: Democrats’ Bill Shows How Not to Get Affordable, Innovative Prescription Drugs
Congressional Democrats have released their latest version of a drug-pricing proposal that would expand government’s role by setting prices for prescription drugs for the...
Congress Considers Warp Speed Path for New Drugs
Originally introduced in 2020, The Promising Pathway Act (PPA) would streamline the provisional approval process for drugs that have been shown to be safe but have not completed years of efficacy trials required by the U.S. Food and Drug Administration (FDA).
Drug Makers Make Case for Expanding COVID Vaccine Approval
The question remains: have the vaccines demonstrated sufficient safety and effectiveness to merit full approval?
House Considers Drug Price Deal That Could Double Costs to Consumers
The biggest myth about prescription drug costs is that they are generally high.
Promising Alzheimer’s Drug Under Attack for Cost
FDA approved Aduhelm under its “accelerated approval pathway” because “it provides a meaningful therapeutic advantage over existing treatments.”
Drug Companies Stall on Generic Drug Releases
The U.S. Food & Drug Administration has approved generic versions of pharmaceutical products at a record-setting pace since 2016, but few of the newly certified products are available to patients, according to an analysis by Iqvia.
‘Merits’ of the Inflation Reduction Act, Another Fiction Unmasked
'Merits' of the Inflation Reduction Act for seniors unmasked, with fewer innovative drugs and $280 billion siphoned from Medicare. (Commentary)
By Ken Blackwell
My, how things have changed...
Out-of-Pocket Medical Costs Will Impact Presidential Election
Health care affordability has implications for the 2024 presidential election, says Drew Altman, president of KFF.
In a recent article, Altman says the most important...
Expensive Cancer Therapies Put Mandatory Treatment Laws to the Test
The Michigan Department of Insurance and Financial Services (DIFS) issued a bulletin reminding health insurance companies they are bound by Michigan law to cover...
‘March-in” Policy Threatens Research for Rare Disease Treatment
The federal government is moving forward with controlling drug costs by approving “march-in” authority on drug pricing.
The Biden administration announced on December 7 that...
Latest article
Assembly-Line Medicine Weakens Doctor-Patient Relationships, Patients’ Health – Interview
Editor’s Note: On July 31, JAMA Network published the results of a survey that found patients’ trust in doctors and hospitals dropped 31 percentage...
Yes, Vote, but Resist the Political Illusion with Elections- Commentary
By John Stonestreet and Glenn Sunshine
Though all elections have consequences—some more than others—they are moments in time. As such, they reflect more than they...
Guidebook Helps Seniors Avoid Costly Mistakes During Medicare Enrollment
Medicare’s annual enrollment period has begun and to help seniors make decisions they will not regret, the non-profit policy organization, the Citizens' Council for...
